AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 35 filers reported holding AXCELLA HEALTH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $196 | -93.4% | 900 | -85.5% | 0.00% | – |
| Q1 2023 | $2,984 | -40.3% | 6,217 | +98.4% | 0.00% | – |
| Q3 2022 | $5,000 | -54.5% | 3,133 | -43.5% | 0.00% | – |
| Q2 2022 | $11,000 | +37.5% | 5,545 | +76.8% | 0.00% | – |
| Q1 2022 | $8,000 | +100.0% | 3,137 | +69.9% | 0.00% | – |
| Q4 2021 | $4,000 | -75.0% | 1,846 | -67.3% | 0.00% | – |
| Q3 2021 | $16,000 | -40.7% | 5,639 | -16.6% | 0.00% | – |
| Q2 2021 | $27,000 | -27.0% | 6,765 | -12.4% | 0.00% | – |
| Q1 2021 | $37,000 | +146.7% | 7,720 | +161.8% | 0.00% | – |
| Q4 2020 | $15,000 | +150.0% | 2,949 | +114.6% | 0.00% | – |
| Q3 2020 | $6,000 | -64.7% | 1,374 | -56.0% | 0.00% | – |
| Q2 2020 | $17,000 | -45.2% | 3,125 | -65.5% | 0.00% | – |
| Q1 2020 | $31,000 | -59.2% | 9,052 | -52.5% | 0.00% | – |
| Q4 2019 | $76,000 | +744.4% | 19,073 | +1168.2% | 0.00% | – |
| Q3 2019 | $9,000 | -40.0% | 1,504 | -8.7% | 0.00% | – |
| Q2 2019 | $15,000 | – | 1,648 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 2,807,981 | $14,573,000 | 5.70% |
| Flagship Pioneering Inc. | 12,548,414 | $65,126,000 | 1.19% |
| Artal Group S.A. | 712,500 | $3,698,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 30,713 | $159,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 132,915 | $690,000 | 0.01% |
| Virtu Financial LLC | 15,682 | $81,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 187,122 | $971,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62,467 | $324,000 | 0.01% |
| FMR LLC | 5,631,132 | $29,226,000 | 0.00% |
| MARSHALL WACE, LLP | 60,307 | $313,000 | 0.00% |